BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25549794)

  • 1. HOXA5 indicates poor prognosis and suppresses cell proliferation by regulating p21 expression in non small cell lung cancer.
    Zhang ML; Nie FQ; Sun M; Xia R; Xie M; Lu KH; Li W
    Tumour Biol; 2015 May; 36(5):3521-31. PubMed ID: 25549794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hoxa5: A Key Player in Development and Disease.
    Jeannotte L; Gotti F; Landry-Truchon K
    J Dev Biol; 2016 Mar; 4(2):. PubMed ID: 29615582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Expression of Homeobox A5 in Endometrial Cancer on the mRNA and Protein Level.
    Dziobek K; Oplawski M; Zmarzły N; Gabarek BO; Kiełbasiński R; Kiełbasiński K; Kieszkowski P; Talkowski K; Boroń D
    Curr Pharm Biotechnol; 2020; 21(7):635-641. PubMed ID: 31880256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physcion blocks cell cycle and induces apoptosis in human B cell precursor acute lymphoblastic leukemia cells by downregulating HOXA5.
    Gao F; Liu W; Guo Q; Bai Y; Yang H; Chen H
    Biomed Pharmacother; 2017 Oct; 94():850-857. PubMed ID: 28810515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel Hoxa5eGFP mouse line.
    Li MH; Kuetemeyer JM; Yallowitz AR; Wellik DM
    Dev Dyn; 2023 Apr; 252(4):536-546. PubMed ID: 36577717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling.
    Ye J; Liu W; Yu X; Wu L; Chen Z; Yu Y; Wang J; Bai S; Zhang M
    Cell Death Discov; 2023 Oct; 9(1):378. PubMed ID: 37845209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen differentially affects the hox proteins Hoxb5 and Hoxa5 altering airway branching and lung vascular formation.
    Silfa-Mazara F; Mujahid S; Thomas C; Vong T; Larsson I; Nielsen HC; Volpe MV
    J Cell Commun Signal; 2014 Sep; 8(3):231-44. PubMed ID: 25073509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
    Teo WW; Merino VF; Cho S; Korangath P; Liang X; Wu RC; Neumann NM; Ewald AJ; Sukumar S
    Oncogene; 2016 Oct; 35(42):5539-5551. PubMed ID: 27157614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXA5 Counteracts Stem Cell Traits by Inhibiting Wnt Signaling in Colorectal Cancer.
    Ordóñez-Morán P; Dafflon C; Imajo M; Nishida E; Huelsken J
    Cancer Cell; 2015 Dec; 28(6):815-829. PubMed ID: 26678341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma.
    Wang CC; Su KY; Chen HY; Chang SY; Shen CF; Hsieh CH; Hong QS; Chiang CC; Chang GC; Yu SL; Chen JJ
    PLoS One; 2015; 10(4):e0124191. PubMed ID: 25875824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is HOXA5 a Novel Prognostic Biomarker for Uterine Corpus Endometrioid Adenocarcinoma?
    Song C; Kim KB; Lee GS; Shin S; Kim B
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Transcription Factor
    Parrillo L; Spinelli R; Longo M; Zatterale F; Santamaria G; Leone A; Campitelli M; Raciti GA; Beguinot F
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer.
    Luo J; Chen S; Chen J; Zhou Y; He F; Wang E
    PLoS One; 2022; 17(12):e0278270. PubMed ID: 36454866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of TWIST1-EVX1 Axis in Invasiveness of Esophageal Squamous Cell Carcinoma; a Functional Study.
    Ardalan Khales S; Abbaszadegan MR; Hosseini SE; Forghanifard MM
    Iran J Biotechnol; 2022 Apr; 20(2):e2733. PubMed ID: 36337061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis.
    Otálora-Otálora BA; Osuna-Garzón DA; Carvajal-Parra MS; Cañas A; Montecino M; López-Kleine L; Rojas A
    Biology (Basel); 2022 Jul; 11(7):. PubMed ID: 36101460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers.
    Lacombe V; Lenaers G; Urbanski G
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Profiles of HOXC6 Predict the Survival of Glioblastoma Patients and Correlate with Cell Cycle.
    Li ZH; Ma Y; Zhou Y; Huang ZH
    J Oncol; 2022; 2022():8656865. PubMed ID: 35432534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of EZH2 and HOXA5 with non-small cell lung carcinoma patient survival rate.
    Li Y; Cui L; Li H; Li Y; Wang X; Ma N; Zhang X
    Transl Cancer Res; 2020 Mar; 9(3):1761-1767. PubMed ID: 35117523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular implications of HOX genes targeting multiple signaling pathways in cancer.
    Shenoy US; Adiga D; Kabekkodu SP; Hunter KD; Radhakrishnan R
    Cell Biol Toxicol; 2022 Feb; 38(1):1-30. PubMed ID: 34617205
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.